Abstract
Alzheimer’s disease (AD) is a degenerative brain disorder that manifests as a progressive deterioration of memory and mental function—a state of mind commonly referred to as “dementia” and causes changes in personality and behavior. AD was first described in 1906 by German neuropsychiatries Prof. Alois Alzheimer. Major pathological hallmarks of AD are characterized by deposition of abnormal amyloid β protein plaques, formation of neurofibrillary tangles of tau protein, and decline in cholinergic neurotransmission in brain. During the last decade, significant growth in Alzheimer’s prevalence has ignited the importance of more researches in the search of new medicine. One of the major clinical advances in the treatment of AD has been the use of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitors to alleviate ACh level in brain although cholinergic compounds with nicotinic and muscarinic agonist properties also have attracted some interest. At present, there are very limited medications available to treat AD and most of the treatment is available only to delay the progression of symptoms and symptomatic relief for a short period of time. Medicinal plants represent a great deal of untapped reservoir of natural medicines and a potential source of natural AChE inhibitors. The structural diversity of their phytoconstituents makes them a valuable source of novel lead compounds for the quest of drugs to treat AD. Therefore, systematic ethnopharmacological screening of these plants may provide useful leads in the discovery of new drugs for AD therapy. With this background, a systematic review is prepared to bring forth an updated knowledge in various phytoextracts and their derivatives along with their possible action on cholinergic nervous system to ease AD therapy. Electronic database was used for searching the information related to studies performed in plants during last decades.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abhang RY. Medhya rasayana: past, present and future. Deerghayu Int. 1987;4:8–18.
Adewusi EA, Steenkamp V. In vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Southern Africa. Asian Pac J Trop Med. 2011;5(2):829–35.
Ahirwar S, Tembhre M, Gour S, Namdeo A. Anticholinesterase efficacy of Bacopa monnieri against the brain regions of rat—a novel approach to therapy for Alzheimer’s disease. Asian J Exp Sci. 2012;26(1):65–70.
Ahmed T, Gilani AH. Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer’s disease. Pharmacol Biochem Behav. 2009;91:554–9.
Aisen PS. Anti-inflammatory agents in Alzheimer’s disease. Curr Neurol Neurosci Rep. 2002a;2:405–52.
Aisen PS. Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer’s disease. J Pain Symptom Manag. 2002b;23:S35–42.
Akhlaq AF, Tahira F, Anil M, Jolin Hwee-Jing O, Wei-Yi O. Ayurvedic medicine for the treatment of dementia: mechanistic aspects. Evid Based Complement Alternat Med. 2018;40(2):1–11.
Akinrimisi ED, Ainwannde AI. Effect of aqueous extract of Eugenia caryolphyllus on brain acetylcholinesterase in rats. West Afr J Pharmacol Drug Res. 1975;2:127–33.
Amod PK, Laurie AK, Girish JK. Herbal complement inhibitors in the treatment of neuroinflammation. Ann N Y Acad Sci. 2005;1056:413–29.
Anderson RN. Deaths: leading causes for 2000. Natl Vital Stat Rep. 2002;50:1.
Anil K, Samrita D, Atish P. Neuroprotective effects of Centella asiatica against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress. Int J Alzheimer’s Dis. 2009;9:1–8.
Atanu B, Shastry CS, Saha S. Nootropic activity of Crataeva nurvala Buch-ham against scopolamine induced cognitive impairment. EXCLI J. 2015;14:335–45.
Bahr BA, Bendiske J. The neuropathogenic contributions of lysosomal dysfunction. J Neurochem. 2002;83:481–92.
Bajaj S, Vohora SB. Anticataleptic, anti-anxiety and anti-depressant activity of gold preparation used in Indian systems of medicine. Indian J Pharmacol. 2000;32:339.
Bajaj S, Ahamad I, Fatima M, Raisuddin S, Vohora SB. Immunomadulatory activity of a Unani gold preparation used in Indian system of medicine. Immunopharmacol Immunotoxicol. 1999;21:151.
Berrino F. Western diet and Alzheimer’s disease. Epidemiol Prev. 2002;26:107.
Bhattacharya SK, Kumar A. Effect of glycowithanolides from Withania somnifera on an animal model of Alzheimer’s disease and perturbed central cholinergic markers of cognition in rats. Phytother Res. 1995;9:110–6.
Boral GC, Gautam B, Anjan B, Das NN, Nandi PS. Geriforte in anxiety neurosis. Indian J Psychiatry. 1989;31(3):258–60.
Bush AI. The metallobiology of Alzheimer’s disease. Trends Neurosci. 2003;26(4):207–14.
Carlo C, William LG, Michael L, Dale K, Kerry B, Barry O. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med. 2008;14(6):707–13.
Chatellier G, Lacomblez L. Tacrine (teterahydroaminoacridine; THA) and lecithine in senile dementia of the Alzheimer type: a multicenter trial. Br Med J. 1990;300:495.
Clegg BJ, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N. Clinical and cost effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer’s disease: a systematic review. Int J Technol Assess Health Care. 2002;18:497.
Colucci L, Bosco M, Ziello AR, et al. Effectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: a review. J Exp Pharmacol. 2012;4:163–72.
Dahanukar SA, Kulkarni RA, Rege NN. Pharmacology of medicinal plants and natural products. Indian J Pharmacol. 2000;32:S81–S118.
Dash SC, Tripathi SN, Singh RH. Clinical assessment of medhya drugs in the management of psychosis (unmada). Ancient Sci Life. 1983;3:77–83.
Divya SV, Lakshmi CM. Alzheimer’s disease. Scientific basis for Ayurvedic medicines. New York: CRC Publishers; 2007.
Doraiswamy PM. Non-cholinergic strategies for treating and preventing Alzheimer’s disease. CNS Drugs. 2002;16:24.
Dwivedi KK, Singh RH. A clinical study of medhya rasayana therapy in the management of convulsive disorder. J Res Ayurveda Siddha. 1978;13:97.
Fernando GP. Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci. 2008;9(7):568–78.
Frawley D. Ayurvedic Healing. Delhi, India: Motilal Banarsidass Publishers; 1989.
Gelb DJ. Measurement of progression in Alzheimer’s disease: a clinician perspective. Stat Med. 2000;19:1390–8.
Ghosh AK, Osswald HL. BACE1 (β-Secretase) inhibitors for the treatment of Alzheimer’s disease. Chem Soc Rev. 2014;43(19):6765–813. https://doi.org/10.1039/c3cs60460h.
Gohil KJ, Patel JA. A review on Bacopa monniera: current research and future prospects. Int J Green Pharma. 2010;2:1–9.
Gupta BM, Bala A. Alzheimer’s disease research in India: a scientometric analysis of publications output during 2002–11. Res Neurol Int J. 2013;2013:11. https://doi.org/10.5171/2013.204542.
Habibur R, Muralidharan P, Anand M. Inhibition of AChE and antioxidant activities are probable mechanism of Nardostacys Jatamansi DC in sleep deprived Alzheimer’s mice model. Int J Pharma Tech Res. 2011;3(3):1807–16.
Handa SS, Bhargava VK. Effect of BR 16-A (Mentat) on cognitive deficits in aluminum treated and aged rats. Indian J Pharmacol. 1997;28:258–64.
Harvey AL. Natural products in drug discovery. Drug Discov Today. 2008;13:894–901.
Howes MJ, Houghton PJ. Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav. 2003;75:513–27.
Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell. 2012;148(6):1204–22.
Huang W, Zhang X, Chen W. Role of oxidative stress in Alzheimer’s disease. Biomed Rep. 2016;4(5):519–22.
Ingkaninan K, Phengpa P, Yuenyongsawad S, Khorana N. Acetylcholinesterase inhibitors from Stephania venosa tuber. J Pharm Pharmacol. 2006;58:695–700.
Iyer MR, Pal SC, Kasture VS, Kasture SB. Effect of Lawsonia inermis on memory and behaviour mediated via monoamine neurotransmitters. Ind J Pharmacol. 1998;30:181–5.
Jagdeep SD, Prasad DN, Avinash CT, Rajiv G. Role of traditional medicine in neuropsychopharmacology. Asian J Pharm Clin Res. 2009;2(2):72–6.
Jemima J, Bhattacharjee P, Singhal RS. Melatonin—a review on the lesser known potential nutraceutical. Int J Pharm Sci Res. 2011;2(8):1975–87.
Jian-zhi W, Ze-fen W. Role of melatonin in Alzheimer-like neurodegeneration. Acta Pharmacol Sinica. 2006;27(1):41–9.
Jivad N, Rabiei Z. A review study on medicinal plants used in the treatment of learning and memory impairments. Asian Pac J Trop Biomed. 2014;4:780–9.
Kar S, Slowikowski SPM, Westaway D, Mount HTJ. Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer’s disease. J Psychiatry Neurosci. 2004;29(6):427–41.
Kashmira JG, Jagruti P, Anuradha KG. Pharmacological review on Centella asiatica: a potential herbal cure-all. Ind J Pharma Sci. 2010;72(5):546–56.
Keyvan D, Damien Dorman HJ, Heikki V, Raimo H. Plants as potential sources for drug development against Alzheimer’s disease. Int J Biomed Pharm Sci. 2007;1(2):83–104.
Khare CP. Indian medicinal plants an illustrated dictionary. Berlin: Springer; 2007.
Kulkarni SK, Verma A. BR 16-A (Mentat): a herbal preparation improves learning and memory performance in mice. PRO. 1994;3(222):28.
Lemstra AW, Eikelenboom P, Van Gool WA. The cholinergic deficiency syndrome and its therapeutic implications. Gerontology. 2003;49:55.
Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB, McDowell I. Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian study of health and aging. Am J Epidemiol. 2002;156:445–52.
Mahesh G, Tasneem S. Biomarker controversies and diagnostic difficulties in Alzheimer’s disease. Am J Phytomed Clin Therap. 2014;2(4):463–8.
Manyam BV. Dementia in Ayurveda. J Altern Complement Med. 1999;5:81–8.
Maya M, Sarada S. In vitro screening for anti-cholinesterase and antioxidant activity of methanolic extracts of Ayurvedic medicinal plants used for cognitive disorders. PLoS One. 2014;9(1):e86804.
Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev. 2000;5:334–46.
Mukherjee PK, Kumar V, Mal M, Houghton PJ. Acetylcholinesterase inhibitors from plants. Phytomedicine. 2007;14:289–300.
Muralidharan P, Balamurugan G, Venu B. Cerebroprotective effect of Glycyrrhiza glabra Linn. root extract on hypoxic rats. Bangladesh J Pharmacol. 2009;4:60–4.
Nillert W, Pannangrong W, Welbat JU. Neuroprotective effects of aged garlic extract on cognitive dysfunction and neuroinflammation induced by β-amyloid in rats. Nutrients. 2017;9:24–36.
Orhan I, Kartal M, Naz Q, Ejaz A, Yilmaz G, Kan Y, et al. Antioxidant and anticholinesterase evaluation of selected Turkish Salvia species. Food Chem. 2007;103:1247–54.
Patel VS, Jivani NP, Patel SB. Medicinal plants with potential nootropic activity: a review. Res J Pharm Bio Chem Sci. 2014;5(1):1–11.
Perry EK, Pickering AT, Wang WW, Houghton PJ, Perry NS. Medicinal plants and Alzheimer’s disease: from ethnobotany to phytotherapy. J Pharm Pharmacol. 1999;51:527–33.
Perry NSL, Houghton PJ, Theolad AE, Jenner P, Perry EK. In vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. J Pharm Pharmacol. 2000;52:895–902.
Perry NSL, Houghton PJ, Sampson J, Theolad AE, Hart S, Lis-balchin M. In vitro activities of Salvia lavandulaefolia (Spanish Sage) relevant to treatment of Alzheimer’s disease. J Pharm Pharmacol. 2001;53:1347–56.
Philomena G. Concerns regarding the safety and toxicity of medicinal plants—an overview. J Appl Pharma Sci. 2011;1(6):40–4.
Prachi S, Lakshmayya L, Vinod SB. Anti-Alzheimer activity of isolated karanjin from Pongamia pinnata (L.) pierre and embelin from Embelia ribes Burm.f. Int Quarterly J Res Ayurveda. 2017;38(1):76–81.
Prakash R, Sandhya E, Ramya N, Dhivya R, Priyadarshini M, Sakthi Priya B. Neuroprotective activity of ethanolic extract of Tinospora cordifolia on LPS induced neuroinflammation. Transl Biomed. 2017;8(4):135–42.
Prerna U, Vikas S, Mushtaq A. Therapy of Alzheimer’s disease: an update. Afr J Pharm Pharmacol. 2010;4(6):408–21.
Puchchakayala G, Akina S, Thati M. Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress. Int J Alzheimers Dis. 2012;12:1–8.
Rammohan VR, Olivier D, Varghese J, Dale EB. Ayurvedic medicinal plants for Alzheimer’s disease: a review. Alzheimers Res Ther. 2012;4(22):1–12.
Rhee IK, Meent MV, Ingkaninan K, Verpoorte R. Screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining. J Chromatogr. 2001;915:217–23.
Rinne JO, Kaasinen V, Jarvenpaa T, Någren K, Roivainen A, Yu M, et al. Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer’s disease. Neurol Neurosurg Psychiatry. 2003;74:113–5.
Roberts SB. Gamma-secretase inhibitors and Alzheimer’s disease. Adv Drug Deliv Rev. 2002;54:1579–82.
Satyavati GV, Gupta AK, Tandon N, Seth SD. Medicinal plants of India, Vol. 2. New Delhi, India: Indian Council of Medical Research; 1987.
Schiloers R, Liermann A, Bhattacharya SK, Kumar A, Ghoshal S, Rich V. Systemic administration of defined extracts from Withania Somnifera (Indian ginseng) and shilajit differentially affects cholinergic but not glutaminergic and gabaergic markers in rat brain. Neurochem Int. 1997;30:181.
Schneider LS. New therapeutic approaches to Alzheimer’s disease. Psychiatry. 1996;57:30–6.
Sharma PC, Yelne MB, Dennis TJ. Database on medicinal plants used in Ayurveda and Sidha. 1st ed. New Delhi: CCRAS, Dept. of AYUSH, Ministry of Health and Family Welfare, Govt. of India; 2005.
Singh RH, Sinha BN, Sarkar FH, Udupa KN. Comparative biochemical studies on the effect of four Medhya Rasayana drugs described by Caraka on some central neurotransmitters in normal and stressed rats. J Indian Med Yoga Homeopathy. 1979;14:7–14.
Soumyanath S, Zhong Y, Henson E, et al. Centella asiatica extract improves behavioral deficits in a mouse model of Alzheimer’s disease: investigation of a possible mechanism of action. Int J Alzheimers Dis. 2012;12:381–94.
Spiegel R. Rivastigmine: a review of its clinical effectiveness. Rev Neurol. 2002;35:859.
Talic S, Dragicevic I, Corajevic L, Martinovic BA. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of extracts from medicinal plants. Bulletin Chemists Technol Bosnia Herzegovania. 2014;43:11–4.
Uma G, Uma Maheswari S. Neuroprotective effects of polyherbal formulation (Indian Noni) on scopolamine-induced memory impairment in mice. Int J Pharm Pharm Sci. 2014;6(1):354–7.
Urbain A, Marston A, Queiroz EF, Ndjoko K, Hostettmann K. Xanthones from Gentiana campestris as new acetylcholinesterase inhibitors. Planta Med. 2004;70:1011–4.
Vaidya AB. The status and scope of Indian medicinal plants acting on the central nervous system. Indian J Pharmacol. 1997;29(S340):228–34.
Vinutha B, Prashanth D, Salma K, Sreeja SL, Pratiti D, Padmaja R, et al. Screening of selected Indian medicinal plants for acetylcholinesterase inhibitory activity. J Ethnopharmacol. 2007;109:359–63.
Vladimir V, Sophia R. Results of beta secretase-inhibitor clinical trials support amyloid precursor protein-independent generation of beta amyloid in sporadic Alzheimer’s disease. Med Sci (Basel). 2018;6(2):45–58.
Vohora SB, Kim HS, Shah SA, Khanna T, Dandiya PC. CNS and adaptogenic effects of Siddh Makardhwaja: an Ayurvedic mercury preparation, in trace elements in nutrition and health. New Delhi, India: Jamia Hamdard and Wiley Eastern Ltd.; 1995.
Wang BS, Wang H, Wei ZH, Song YY, Zhang L, Chen HZ. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: an updated meta-analysis. J Neural Transm. 2009;116(4):457–65.
Zhang F, Jiang L. Neuroinflammation in Alzheimer’s disease. Neuropsychiatr Dis Treat. 2015;11:243–56.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Bhattacharjee, A., Chakraborty, R., Sen, S. (2020). Scientific Basis for Ayurvedic Medicinal Plants Against Alzheimer’s Disease. In: Sen, S., Chakraborty, R. (eds) Herbal Medicine in India. Springer, Singapore. https://doi.org/10.1007/978-981-13-7248-3_5
Download citation
DOI: https://doi.org/10.1007/978-981-13-7248-3_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7247-6
Online ISBN: 978-981-13-7248-3
eBook Packages: MedicineMedicine (R0)